Loading organizations...
Key people at Jumpstart Ventures.
Jumpstart Ventures was founded in 2011 by Shradha Agarwal (Founder & Managing Partner).
Jumpstart Ventures is an early-stage venture capital firm based in Cleveland, Ohio, that invests in tech startups from seed through Series A stages. The firm manages $140 million across a continuum of funds, supporting over 170 portfolio companies by providing capital, strategic advising, industry connections, and accelerator programs. Its investment thesis centers on breakthrough technologies within high-opportunity markets, aiming to help founders achieve product-market fit, scale operations, and attract further capital. While the specific founders of Jumpstart Ventures are not publicly disclosed, the broader JumpStart Inc. organization, which Jumpstart Ventures is affiliated with, was founded in 2003. Notable figures associated with related Jumpstart entities include Ray Leach, CEO of JumpStart Inc., and Jumpstart Health Investors co-founders Vic Gatto and Marcus Whitney.
Key people at Jumpstart Ventures.
Jumpstart Ventures was founded in 2011 by Shradha Agarwal (Founder & Managing Partner).
JumpStart Ventures is an early‑stage venture firm that provides capital, operating support and network access to seed–Series A technology and healthcare startups primarily in Ohio and the U.S. Midwest, with a stated mission to drive economic impact by helping founders scale market‑defining companies from the region.[2][6]
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick reference back to the opening hook: JumpStart Ventures is best understood as a regionally rooted, multi‑fund early‑stage investor that combines capital, hands‑on services and a broad co‑investor network to help B2B software and healthcare startups in Ohio and the Midwest scale toward national markets and follow‑on capital.[2][3][1]
Jumpstart Ventures has 22 tracked investments across 21 companies. The latest tracked deal is $7.5M Other Equity in orthobrain in April 2025.